InvestSMART

Biotron Limited (ASX: BIT) - Announcements

- Current share price for BIT : $0.002

ASX company news and announcements for Biotron Limited (BIT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biotron Limited (BIT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biotron Limited (BIT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biotron Limited (BIT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4C - quarterly 27 Oct 2011 10:59AM $0.125 $0.002 fallen by 98.40%
$6 HEPATITIS C PHASE 2A TRIAL POSITIVE RESULTS 10 Oct 2011 10:46AM $0.125 $0.002 fallen by 98.40%
$6 Trading Halt 7 Oct 2011 1:05PM $0.097 $0.002 fallen by 97.94%
$6 Landmark HIV Trial Underway 29 Sep 2011 9:57AM $0.098 $0.002 fallen by 97.96%
$6 Year End Accounts and Preliminary Final Report 30 Aug 2011 9:15AM $0.110 $0.002 fallen by 98.18%
$6 Appendix 4C - quarterly 27 Jul 2011 10:12AM $0.100 $0.002 fallen by 98%
$6 Appendix 4C - quarterly 19 Apr 2011 3:04PM $0.100 $0.002 fallen by 98%
$6 New Issue - Appendix 3B 4 Apr 2011 9:40AM $0.115 $0.002 fallen by 98.26%
$6 Trading Halt 31 Mar 2011 10:03AM $0.115 $0.002 fallen by 98.26%
$6 Stage 1 of Landmark HCV Drug Trial Completed 10 Mar 2011 11:57AM $0.096 $0.002 fallen by 97.92%
$6 Half Yearly Report and Accounts 28 Feb 2011 4:35PM $0.100 $0.002 fallen by 98%
$6 Biotron Share Purchase Plan 24 Feb 2011 11:34AM $0.098 $0.002 fallen by 97.96%
$6 Response to ASX Query re Appendix 4C 7 Feb 2011 9:40AM $0.115 $0.002 fallen by 98.26%
$6 Appendix 4C - quarterly 27 Jan 2011 5:02PM $0.095 $0.002 fallen by 97.89%
$6 International Study Supports Biotron`s HIV Drug Approach 25 Nov 2010 10:48AM $0.145 $0.002 fallen by 98.62%
$6 Appendix 4C - quarterly 27 Oct 2010 12:26PM $0.110 $0.002 fallen by 98.18%
$6 Phase II HCV Trial Commenced 1 Oct 2010 10:10AM $0.064 $0.002 fallen by 96.88%
$6 Preliminary Final Report 31 Aug 2010 4:17PM $0.130 $0.002 fallen by 98.46%
$6 Appendix 4C - quarterly 30 Jul 2010 11:05AM $0.060 $0.002 fallen by 96.67%
$6 Presentation at International AIDS Conference 23 Jul 2010 11:00AM $0.075 $0.002 fallen by 97.33%
$6 Appendix 4C - quarterly 22 Apr 2010 4:54PM $0.095 $0.002 fallen by 97.89%
$6 Biotron HCV Drug - International Partner to Progress Trial 18 Mar 2010 2:52PM $0.096 $0.002 fallen by 97.92%
$6 Half Yearly Report and Accounts 26 Feb 2010 1:42PM $0.100 $0.002 fallen by 98%
$6 Appendix 4C - quarterly 27 Jan 2010 10:46AM $0.099 $0.002 fallen by 97.98%
$6 Breakthrough HIV Treatment Progresses 17 Dec 2009 10:19AM $0.110 $0.002 fallen by 98.18%

501 - 525 of 594 results

Page 21 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.